Archived articles


Cancer research
Novel AI blood test detects liver cancer
Published Nov 21, 2022
The test, developed by researchers at the Johns Hopkins Kimmel Cancer Center, aids in early detection of liver cancer—one of the leading causes of cancer deaths
Faculty spotlight
Celebrated cancer researcher Chi Van Dang returns to Johns Hopkins
Published Nov 14, 2022
The alumnus and former faculty member of the School of Medicine has been named the Bloomberg Distinguished Professor of cancer medicine
Cancer research
A new microfluidic system could keep tabs on cancer treatment
Published Aug 2, 2022
A new system developed by Johns Hopkins researchers could monitor drug resistance in elusive cancer cells and open the door for more effective treatment options
Tying it all together
Published May 17, 2022
Post-doctoral fellow Ashley Kiemen synergized her love for math, visual artistry, and biology by co-developing a platform to create interactive, 3D models of human tissue to improve the study of tumor formation
Giants of the genome field
Published Spring 2022
Bert Vogelstein and Ken Kinzler continue their decadeslong search for cancer's elusive cure / Johns Hopkins Magazine
Cancer Moonshot renewal could bring ambitious goals within reach
Published Feb 8, 2022
Johns Hopkins cancer researcher Elizabeth Jaffee, who co-led the Cancer Moonshot Blue Ribbon Panel in 2016, discusses how far cancer research has come in the past five years and where it's headed in the next few decades
Cancer research
Pioneering method examines how immunotherapy changes tumors
Published Oct 13, 2021
The non-invasive technique using an optical probe provides early signs of how a tumor is responding to treatment
Diversity in the fight against cancer
Published Sept 22, 2021
Age, race, sex—new National Cancer Advisory Board member Ashani Weeraratna says we need to consider diversity to find a cure
Two Hopkins scientists named to National Cancer Advisory Board
Published Sept 16, 2021
Ashi Weeraratna, Nilo Azad among seven selected to advise National Cancer Institute director on activities of the national cancer program
Cancer research
Startup founders from Johns Hopkins aim to stop spread of cancer
Published July 28, 2021
AbMeta Therapeutics, launched by biologist and Provost Denis Wirtz, bioengineer Jamie Spangler, and clinician Elizabeth Jaffee, will combine years of pioneering research to create new drugs that target metastasis